Trueblue (TBI – Research Report), the Industrials sector company, was revisited by a Wall Street analyst today. Analyst Jeffrey Silber from BMO Capital maintained a Buy rating on the stock and has a $11.00 price target.
Jeffrey Silber has given his Buy rating due to a combination of factors that suggest potential growth and competitive advantages for Trueblue. Despite the current cautious environment, the company has identified promising opportunities in its energy renewal and “Southern border” businesses, which are expected to benefit from ongoing policy changes and increased demand.
Additionally, Trueblue’s recent acquisition of Healthcare Staffing Partners is seen as a strategic move to enter high-growth markets and leverage its existing capabilities to expand efficiently. The company’s national scale, local presence, and technological strengths are anticipated to help it gain market share as conditions improve. These factors, combined with signs of stabilization in the staffing industry, contribute to Silber’s optimistic outlook on Trueblue’s stock.